Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage
Patent
·
OSTI ID:1805449
The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- Assignee:
- Los Alamos National Security, LLC (Los Alamos, NM)
- Patent Number(s):
- 10,906,941
- Application Number:
- 14/784,496
- OSTI ID:
- 1805449
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nucleic acids encoding mosaic HIV-1 gag proteins
HIV-1 envelope glycoprotein
Mosaic vaccines elicit CD8+ T cell responses in monkeys that confer immune coverage of diverse HIV strains
Patent
·
2016
·
OSTI ID:1332283
HIV-1 envelope glycoprotein
Patent
·
2017
·
OSTI ID:1376215
Mosaic vaccines elicit CD8+ T cell responses in monkeys that confer immune coverage of diverse HIV strains
Journal Article
·
2008
· Journal of Science
·
OSTI ID:971295